Tiffany A. Wallace

2.4k total citations · 1 hit paper
20 papers, 1.4k citations indexed

About

Tiffany A. Wallace is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Tiffany A. Wallace has authored 20 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 10 papers in Molecular Biology and 6 papers in Cancer Research. Recurrent topics in Tiffany A. Wallace's work include Cytokine Signaling Pathways and Interactions (6 papers), Protein Kinase Regulation and GTPase Signaling (4 papers) and Pharmacological Effects of Natural Compounds (4 papers). Tiffany A. Wallace is often cited by papers focused on Cytokine Signaling Pathways and Interactions (6 papers), Protein Kinase Regulation and GTPase Signaling (4 papers) and Pharmacological Effects of Natural Compounds (4 papers). Tiffany A. Wallace collaborates with scholars based in United States, Ireland and Jamaica. Tiffany A. Wallace's co-authors include Stefan Ambs, Robert M. Stephens, Ming Yi, Robyn L. Prueitt, Harris G. Yfantis, Tiffany M. Howe, Robert Hudson, Carlo M. Croce, George A. Calin and Christopher A. Loffredo and has published in prestigious journals such as PLoS ONE, Cancer Research and Clinical Cancer Research.

In The Last Decade

Tiffany A. Wallace

20 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Genomic Profiling of MicroRNA and Messenger RNA Reveals Deregulated MicroRNA Expression in Prostate Cancer

2008 591 citations Stefan Ambs, Robyn L. Prueitt et al. Cancer Research profile →

Peers

Countries citing papers authored by Tiffany A. Wallace

Since Specialization

Citations

This map shows the geographic impact of Tiffany A. Wallace's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tiffany A. Wallace with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tiffany A. Wallace more than expected).

Fields of papers citing papers by Tiffany A. Wallace

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tiffany A. Wallace. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tiffany A. Wallace. The network helps show where Tiffany A. Wallace may publish in the future.

Co-authorship network of co-authors of Tiffany A. Wallace

This figure shows the co-authorship network connecting the top 25 collaborators of Tiffany A. Wallace. A scholar is included among the top collaborators of Tiffany A. Wallace based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tiffany A. Wallace. Tiffany A. Wallace is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The NCI Center to Reduce Cancer Health Disparities: Moving Forward to Eliminate Cancer Health Disparities and Diversify the Cancer Biomedical Workforce 2020 ·Journal of the National Medical Association ·(unknown), Mary Ann S. Van Duyn, (unknown), (unknown), LeeAnn O. Bailey, Alison J. Lin, Tiffany A. Wallace, Frederick R. Snyder	11
2	Abstract B051: IFNL4-deltaG allele is associated with an interferon signature in tumors and survival of African-American men with prostate cancer 2020 ·Cancer Epidemiology Biomarkers & Prevention ·Wei Tang, Tiffany A. Wallace, Ming Yi, Cristina Magi‐Galluzzi, (unknown), Olusegun O. Onabajo, Adeola Obajemu, (unknown), Christopher A. Loffredo, Robert M. Stephens, Robert H. Silverman, George R. Stark, Eric Klein, Ludmila Prokunina‐Olsson, Stefan Ambs	2
3	Impact of Erosion on the Nutrient and Chemical Profiles of Agricultural Soil in the Upper Rio Grande Valley, Jamaica 2020 ·Goldschmidt Abstracts ·Tiffany A. Wallace, (unknown), Donovan Campbell, David J.P. Barker	1
4	IFNL4 -ΔG Allele Is Associated with an Interferon Signature in Tumors and Survival of African-American Men with Prostate Cancer 2018 ·Clinical Cancer Research ·Wei Tang, Tiffany A. Wallace, Ming Yi, Cristina Magi‐Galluzzi, Tiffany H. Dorsey, Olusegun O. Onabajo, Adeola Obajemu, (unknown), Christopher A. Loffredo, Robert M. Stephens, Robert H. Silverman, George R. Stark, Eric A. Klein, Ludmila Prokunina‐Olsson, Stefan Ambs	38
5	Abstract 536: Human endogenous retrovirus K expression as a possible adjunct to PSA in the diagnosis of prostate cancer 2015 ·Cancer Research ·(unknown), Laura S. Murillo, Teresa McHale, Tiffany A. Wallace, (unknown), Aaron J. Schetter, Tiffany H. Dorsey, Carol Johnson, Radoslav Goldman, Christopher A. Loffredo, Peisha Yan, Francis Sullivan, Francis J. Giles, Feng Wang‐Johanning, Stefan Ambs, Sharon A. Glynn	1
6	Elevated HERV-K mRNA expression in PBMC is associated with a prostate cancer diagnosis particularly in older men and smokers 2014 ·Carcinogenesis ·Tiffany A. Wallace, (unknown), (unknown), Aaron J. Schetter, Tiffany H. Dorsey, Carol Johnson, Radoslav Goldman, Christopher A. Loffredo, Peisha Yan, Francis Sullivan, Francis J. Giles, Feng Wang‐Johanning, Stefan Ambs, Sharon A. Glynn	79
7	Household Income Is Associated with the p53 Mutation Frequency in Human Breast Tumors 2013 ·PLoS ONE ·(unknown), Damali N. Martin, Tiffany H. Dorsey, Brenda J. Boersma, Tiffany A. Wallace, Stefan Ambs	8
8	Abstract 1876: Preclinical efficacy of fibroblast growth factor ligand trap HGS1036 in lung carcinoma models with genomic amplification of FGFR1 2012 ·Cancer Research ·Thomas Harding, Servando Palencia, Tiffany A. Wallace, (unknown), Namrata S. Patil, (unknown), (unknown), Li Long, Robin Humphreys, (unknown), Kevin P. Baker	1
9	Interactions among genes, tumor biology and the environment in cancer health disparities: examining the evidence on a national and global scale 2011 ·Carcinogenesis ·Tiffany A. Wallace, (unknown), Stefan Ambs	93
10	Genomic Profiling of MicroRNA and Messenger RNA Reveals Deregulated MicroRNA Expression in Prostate Cancer breakdown → 2008 ·Cancer Research ·Stefan Ambs, Robyn L. Prueitt, Ming Yi, Robert Hudson, Tiffany M. Howe, Fabio Petrocca, Tiffany A. Wallace, Chang‐Gong Liu, Stefano Volinia, George A. Calin, Harris G. Yfantis, Robert M. Stephens, Carlo M. Croce	591
11	Tumor Immunobiological Differences in Prostate Cancer between African-American and European-American Men 2008 ·Cancer Research ·Tiffany A. Wallace, Robyn L. Prueitt, Ming Yi, Tiffany M. Howe, John W. Gillespie, Harris G. Yfantis, Robert M. Stephens, Neil E. Caporaso, Christopher A. Loffredo, Stefan Ambs	386
12	Expression of microRNAs and protein‐coding genes associated with perineural invasion in prostate cancer 2008 ·The Prostate ·Robyn L. Prueitt, Ming Yi, Robert Hudson, Tiffany A. Wallace, Tiffany M. Howe, Harris G. Yfantis, Dong Hoon Lee, Robert M. Stephens, Chang‐Gong Liu, George A. Calin, Carlo M. Croce, Stefan Ambs	130
13	Gene expression profiling reveals tumor immunobiological differences in prostate cancer between African-American and European-American men 2007 ·Tiffany A. Wallace, Robyn L. Prueitt, Ming Yi, Robert M. Stephens, Stefan Ambs	1
14	A functional Jak2 tyrosine kinase domain is essential for mouse development 2006 ·Experimental Cell Research ·Kristen Frenzel, Tiffany A. Wallace, (unknown), Hong Xiao, Mario R. Capecchi, Kenneth E. Bernstein, Peter P. Sayeski	9
15	Jak2 Tyrosine Kinase: A Mediator of Both Housekeeping and Ligand-Dependent Gene Expression? 2006 ·Cell Biochemistry and Biophysics ·Tiffany A. Wallace, Peter P. Sayeski	9
16	Dynamic MRI evaluation of the triple receptor tyrosine kinase inhibitor BIBF 1120 in patients with advanced solid tumours 2006 ·Anwar R. Padhani, N. Jane Taylor, James A. d’Arcy, Simon Walker‐Samuel, David J. Collins, Brett Knowles, (unknown), Tiffany A. Wallace, Andrew Tang, Graham Temple, G.J.S. Rustin, Martin O. Leach, Paul T. Strickland	5
17	Jak2 tyrosine kinase prevents angiotensin II-mediated inositol 1,4,5 trisphosphate receptor degradation 2005 ·Vascular Pharmacology ·Tiffany A. Wallace, Shen‐Ling Xia, Peter P. Sayeski	9
18	Jak2 Tyrosine Kinase: A True Jak of All Trades? 2004 ·Cell Biochemistry and Biophysics ·Eric M. Sandberg, Tiffany A. Wallace, (unknown), (unknown), Peter P. Sayeski	39
19	Microarray analyses identify JAK2 tyrosine kinase as a key mediator of ligand-independent gene expression 2004 ·American Journal of Physiology-Cell Physiology ·Tiffany A. Wallace, (unknown), Kai He, Stuart J. Frank, Peter P. Sayeski	18
20	A True Jak of All Trades 2004 ·Eric M. Sandberg, Tiffany A. Wallace, (unknown), Peter P. Sayeski	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact